NCT07006987Recruiting
HerResolve™ in Detecting the Presence of Endometriosis Among Symptomatic Women
Clinical Study for HerResolve™ in Detecting the Presence of Endometriosis Among Symptomatic Women of Ages 18-49 Years Considering Laparoscopy
Source: ClinicalTrials.gov · Last updated 3 Dec 2025
Brief summary (registry, in English)
Endometriosis (EMS) is a common gynecological disease that affects 176 million girls and women globally. EMS affects 5-10% of women and adolescents within the reproductive age range of 15-49 years, and for those facing infertility, this figure may climb up to 50%. EMS can start at the first menstrual period and last until menopause. Shockingly, between 50% and 80% of women grappling with pelvic pain are found to have EMS. The formation of scar tissue (adhesions, fibrosis) within the pelvis and other parts of the body can cause severe pain and lead to infertility.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- First submitted
- 28 May 2025
- Start date
- Oct 2025
- Primary completion date
- May 2030
- Lead sponsor
- Chinese University of Hong Kong
- Diseases
- Endometriosis
- NCT number
- NCT07006987
What you commit to
- Study type: Interventional
- Planned participants: 100
- From Oct 2025 to the primary completion date, May 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients who are unable or do not undergo laparoscopic surgery
Other illness
- Patients with cancer and/or undergoing chemotherapy and/or radiotherapy
Other
- Patients who object to medical history collection and data requests
- Patients participating in additional interventional clinical studies
- Pregnant, lactating, or subjects who are not healthy enough for blood donation.
- Blood drawn during menses or ovulation phase of menstrual cycle
- Females who are post-menopausa
Who the study is looking for
- Females aged 18 to 49 with mild to severe symptoms of pelvic pain and/or abnormal bleeding.
- Diagnostic laparoscopy is scheduled with histology on any visually suspected endometriosis, and all reports (surgical and pathology) to confirm a positive result. If no visually suspicious endometriotic lesions are seen, biopsies from random areas during the laparoscopy procedure to confirm a negative histopathology result.
- Blood drawn during secretory or proliferative phase of the menstrual cycle
- Provide written informed consent to participate in the study and provide medical history on medications.
Age in the registry: 18 years to 49 years · Sex: Female · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Department of Obstetrics & Gynaecology The Chinese University of Hong Kong Coordinator of this site? Confirm its status | Hong Kong | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.